118 related articles for article (PubMed ID: 1789258)
1. Comparison of the existing nucleoside transport inhibitors: in vitro and in vivo data.
Van Belle H; Wynants J; Ver Donck K
Adv Exp Med Biol; 1991; 309A():419-22. PubMed ID: 1789258
[No Abstract] [Full Text] [Related]
2. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
Plagemann PG; Kraupp M
Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
[TBL] [Abstract][Full Text] [Related]
5. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
6. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside transport in animal cells.
Young JD; Jarvis SM
Biosci Rep; 1983 Apr; 3(4):309-22. PubMed ID: 6347269
[No Abstract] [Full Text] [Related]
8. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
Keil GJ; Delander GE
J Pharmacol Exp Ther; 1995 Sep; 274(3):1387-92. PubMed ID: 7562512
[TBL] [Abstract][Full Text] [Related]
10. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
Prus KL; Averett DR; Zimmerman TP
Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine.
Ijzerman AP; Thedinga KH; Custers AF; Hoos B; Van Belle H
Eur J Pharmacol; 1989 Aug; 172(3):273-81. PubMed ID: 2776845
[TBL] [Abstract][Full Text] [Related]
12. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
Parker MD; Hyde RJ; Yao SY; McRobert L; Cass CE; Young JD; McConkey GA; Baldwin SA
Biochem J; 2000 Jul; 349(Pt 1):67-75. PubMed ID: 10861212
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
Shuralyova I; Tajmir P; Bilan PJ; Sweeney G; Coe IR
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H627-32. PubMed ID: 14551048
[TBL] [Abstract][Full Text] [Related]
15. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
[TBL] [Abstract][Full Text] [Related]
16. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
Plagemann PG
J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
[TBL] [Abstract][Full Text] [Related]
17. Potencies of mioflazine and its derivatives as inhibitors of adenosine transport in isolated erythrocytes from different species.
Baer HP; Haq A; el-Soofi A; Serignese V; Paterson AR
J Pharm Pharmacol; 1990 May; 42(5):367-9. PubMed ID: 1976791
[TBL] [Abstract][Full Text] [Related]
18. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
19. In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters.
Baer HP; Serignese V; Moorji A; Van Belle H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):365-9. PubMed ID: 1852220
[TBL] [Abstract][Full Text] [Related]
20. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
